Yufei Lan

506 citations
14 papers · 290 · 1 hit paper · h-index 9

Impact in

    • Cancer-related molecular mechanisms research
    • Cancer, Hypoxia, and Metabolism
    • MicroRNA in disease regulation
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • Circular RNAs in diseases
    • Cancer-related gene regulation

Papers in

    • RNA Research and Splicing 2
    • Epigenetics and DNA Methylation 2
    • Advanced biosensing and bioanalysis techniques 2
    • RNA modifications and cancer 2
    • Macrophage Migration Inhibitory Factor 2

Yufei Lan

13 papers receiving 289 citations

Yufei Lan's Hit Papers

Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention 2024 · 91 citations
910+1Years since publication255075

Peers

Yufei Lan
Comparison fields: 5 of 52
  • Cancer Research 115
  • Molecular Biology 181
  • Endocrinology 12
  • Biotechnology 16
  • Genetics 15
Replace Paul Yenerall with:
Paul Yenerall United States
Tyler Weirick United States
Xianhong Yu China
Morteza Karimipour Iran
Jiayun Lu China
María V. Revuelta United States
Huiru Sun China
Shuangshuang Mei China
Yufei Lan relative to Paul Yenerall United States Paul Yenerall's profile →
Citations per field
00.5×10.5×
Paul Yenerall · 1×
Citations per year

Countries citing papers authored by Yufei Lan

Since Specialization
Citations

This map shows the geographic impact of Yufei Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Lan more than expected).

Fields of papers citing papers by Yufei Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Lan. The network helps show where Yufei Lan may publish in the future.

Co-authors

The 25 scholars most cited alongside Yufei Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yufei Lan Line = papers co-authored together Yufei Lan links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention
Hit paper breakdown →
202491
2 202162
3 202133
4 201429
5 200720
6 202515
7 202412
8 20239
9 20238
10 20235
11 20252
12 20242
13 20252
14 20250

About Yufei Lan

Yufei Lan is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Genetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 290 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), RNA Research and Splicing (2 papers), Epigenetics and DNA Methylation (2 papers), Macrophage Migration Inhibitory Factor (2 papers), Plant Virus Research Studies (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Glioma Diagnosis and Treatment (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (115 citations), Molecular Biology (181 citations), Endocrinology (12 citations), Biotechnology (16 citations) and Genetics (15 citations). Yufei Lan has collaborated with scholars based in China, Bangladesh and Finland. Frequent co-authors include Hongbo Guo, Boyang Liu, Yue Qu, Tao Yang, Xiangdong Li, Xiaoping Zhu, Chao Geng, Xiaoqing Yu, Ying Wang and Hongyan Wang. Their work appears in journals such as Advanced Science, iScience, Journal of Nanobiotechnology, Chemical Engineering Journal and Molecular Therapy — Nucleic Acids.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact